HMPS — Hempsana Holdings Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Hempsana Holdings, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2006 November 30th | 2007 November 30th | 2020 November 30th | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0.115 | 1.41 |
Cost of Revenue | |||||
Gross Profit | — | — | — | 0.048 | 0.405 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.054 | -0.031 | 0.008 | 4.23 | 2.81 |
Operating Profit | -0.054 | 0.031 | -0.008 | -4.11 | -1.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.054 | 0.031 | -0.008 | -4.24 | -1.48 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.054 | 0.031 | -0.008 | -4.24 | -1.48 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.054 | 0.031 | -0.008 | -4.24 | -1.48 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.054 | 0.031 | -0.008 | -4.24 | -1.48 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.005 | -0.005 | -0.001 | -0.191 | -0.061 |
Dividends per Share |